Another study demonstrated that the use of acetylcholinesterase inhibitors in combination with leuprolide acetate, a gonadotropin-releasing hormone (GnRH- analog that reduces LH secretion), for 48 weeks resulted in the preservation of cognitive function in women with moderate to severe AD [151]. Here, PLOD1 is linked to Alzheimer disease.